Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Karen L. Fearon is active.

Publication


Featured researches published by Karen L. Fearon.


Nature Biotechnology | 2000

Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays

Sydney Brenner; Maria Johnson; John Bridgham; George Golda; David H. Lloyd; Davida Johnson; Shujun Luo; Sarah N. McCurdy; Michael F. Foy; Mark Ewan; Rithy Roth; Dave George; Sam Eletr; Glenn Albrecht; Eric Vermaas; Steven R. Williams; Keith Moon; Timothy Burcham; Michael C. Pallas; Robert B. Dubridge; James J. Kirchner; Karen L. Fearon; Jen-I Mao; Kevin Corcoran

We describe a novel sequencing approach that combines non-gel-based signature sequencing with in vitro cloning of millions of templates on separate 5 μm diameter microbeads. After constructing a microbead library of DNA templates by in vitro cloning, we assembled a planar array of a million template-containing microbeads in a flow cell at a density greater than 3 × 106 microbeads/cm2. Sequences of the free ends of the cloned templates on each microbead were then simultaneously analyzed using a fluorescence-based signature sequencing method that does not require DNA fragment separation. Signature sequences of 16–20 bases were obtained by repeated cycles of enzymatic cleavage with a type IIs restriction endonuclease, adaptor ligation, and sequence interrogation by encoded hybridization probes. The approach was validated by sequencing over 269,000 signatures from two cDNA libraries constructed from a fully sequenced strain of Saccharomyces cerevisiae, and by measuring gene expression levels in the human cell line THP-1. The approach provides an unprecedented depth of analysis permitting application of powerful statistical techniques for discovery of functional relationships among genes, whether known or unknown beforehand, or whether expressed at high or very low levels.


Current protocols in human genetics | 2001

Synthesis and purification of oligonucleotide N3'-->P5' phosphoramidates and their phosphodiester and phosphorothioate chimeras.

Karen L. Fearon; Jeffrey S. Nelson

This unit describes the synthesis and purification of oligonucleotide N3′→︀P5′ phosphoramidates, wherein each 3′‐oxygen is replaced by a 3′‐amine in the 2′‐deoxyribose ring. The synthesis of required monomers and application of the method to preparation of phosphodiester‐ and phosphorothioate‐containing chimera of phosphoramidate is also reported.


Journal of Medicinal Chemistry | 1987

Fluoro ketone containing peptides as inhibitors of human renin

Karen L. Fearon; Andreas Spaltenstein; Michael H. Gelb


Journal of Organic Chemistry | 1997

N3'-->P5' Oligodeoxyribonucleotide Phosphoramidates: A New Method of Synthesis Based on a Phosphoramidite Amine-Exchange Reaction.

Jeffrey S. Nelson; Karen L. Fearon; Mark Q. Nguyen; Sarah N. McCurdy; Jeff E. Frediani; Michael F. Foy; Bernard L. Hirschbein


Journal of Organic Chemistry | 1989

Synthesis of sulfur-substituted phospholipid analogues as mechanistic probes of phospholipase A2 catalysis

Wei Yuan; Karen L. Fearon; Michael H. Gelb


Journal of Organic Chemistry | 1995

SYNTHESIS OF OLIGO(DEOXYRIBONUCLEOSIDE PHOSPHORODITHIOATE)S BY THE DITHIAPHOSPHOLANE APPROACH

Andrzej Okruszek; Agnieszka Sierzchała; Karen L. Fearon; Wojciech J. Stec


Archive | 1996

Solid phase synthesis of oligonucleotide N3'-P5' phosphoramidates

Bernard L. Hirschbein; Karen L. Fearon; Sergei M. Gryaznov; Sarah N. McCurdy; Jeffery S. Nelson; Ronald G. Schultz


Nucleic Acids Research | 1998

An improved synthesis of oligodeoxynucleotide N3′→P5′ phosphoramidates and their chimera using hindered phosphoramidite monomers and a novel handle for reverse phase purification

Karen L. Fearon; Bernard L. Hirschbein; Jeffrey S. Nelson; Michael F. Foy; Mark Q. Nguyen; Sarah N. McCurdy; Jeff E. Frediani; Lawrence A. DeDionisio; Annette M. Raible; E. Neil Cagle; Andrzej Okruszek; Vicky Boyd


Archive | 1996

Synthons for synthesis of oligonucleotide N3-P5 phosphoramidates

Bernard L. Hirschbein; Karen L. Fearon; Sergei M. Gryaznov; Sarah N. McCurdy; Jeffrey S. Nelson; Ronald G. Schultz


Antisense & Nucleic Acid Drug Development | 1999

Comparison of Binding of N3‵→ P5‵ Phosphoramidate and Phosphorothioate Oligonucleotides to Cell Surface Proteins of Cultured Cells

Patricia Hawley; Jeffrey S. Nelson; Karen L. Fearon; Gerald Zon; Ian Gibson

Collaboration


Dive into the Karen L. Fearon's collaboration.

Top Co-Authors

Avatar

Bernard L. Hirschbein

Massachusetts Institute of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Wojciech J. Stec

Food and Drug Administration

View shared research outputs
Top Co-Authors

Avatar

Bogdan Uznanski

Polish Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Andrzej Okruszek

Polish Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge